Meeting your needs
Vision R&D specializes in offering preclinical and clinical ophthalmology research services “from bench to bedside”. Vision R&D can support a wide array of organizations, from start-ups to global pharmaceutical and device companies, to efficiently bring their new products from concept to market. Vision R&D can provide consultation on client goals and objectives, and work with you to design an appropriate study to achieve those objectives.
The ophthalmology experts at Vision R&D apply their “know-how” to develop a global strategy that lead to succeed and save resources, adapted to international standards and to the specifics regulations of each country. Working with the University of Valladolid-IOBA (Eye Institute) allows Vision R&D to keep its costs down, while still providing the knowledge and competency to provide an exceptional service in a timely manner. Clients benefit from a comprehensive solution and expertise for drugs and devices development.
Early Testing
Vision R&D performs pilot studies and proof of concept safety/toxicology/efficacy experiments in validated in vitro and in vivo models that simulate some pathological conditions of the human eye. The ophthalmology experts at Vision R&D help clients determine the most effective direction for future studies. This may include identifying compounds that can be optimized, selecting approved drugs that can be repurposed for other uses, or optimizing an existing drug.
Preclinical Development
Vision R&D performs cutting-edge preclinical studies of ophthalmology drugs and devices. Our ophthalmology experts propose pharmacologic studies in animals and/or in vitro models to investigate the method of action and effects of a substance in the eye. We help clients select the appropriate model and we can also develop new models as needed, according to the specific requirements of our clients.
Clinical Trials
Vision R&D has contrasted experience in performing comprehensive clinical research and development in all areas of ophthalmology, from the ocular surface to the posterior segment of the eye. Vision R&D has expertise in all phases of clinical research – phases 1, 2a, 2b, 3, and post-approval phase 4 studies –. For clinical trials and development, our ophthalmology experts offer clinical operations, subject recruiting, medical writing, regulatory guidance and consulting, data management, and biostatistics services. Clients can choose stand-alone services or global support to test new ocular drugs and devices in humans during clinical development.
